KPV
Description
KPV (Lys-Pro-Val) is a naturally occurring C-terminal tripeptide fragment of alpha-Melanocyte Stimulating Hormone (α-MSH), a peptide with well-established immunomodulatory and anti-inflammatory properties. KPV retains the core anti-inflammatory activity of its parent peptide whilst offering superior stability and a markedly simpler molecular structure. Its small size and favourable physicochemical profile have made it a subject of growing interest in gastrointestinal, dermatological, and systemic inflammation research.
Product Specifications
| Compound | KPV (Lys-Pro-Val) |
| Form | Capsule |
| Capsules per bottle | 60 |
| Concentration | 500mcg per capsule |
| Total yield | 30,000mcg (30mg) per bottle |
| CAS Number | 66003-86-9 |
| Purity | ≥98% (HPLC verified) |
| Storage | Store in a cool, dry place away from direct sunlight. Refrigeration recommended for long-term storage. |
Research Background
KPV exerts its effects primarily through direct interaction with melanocortin receptors (MC1R, MC3R) and via intracellular inhibition of pro-inflammatory signalling cascades, including NF-κB pathway suppression. Its ability to penetrate epithelial barriers and act locally within mucosal tissue has positioned it as a particularly valuable tool in gut inflammation research. Key areas of active scientific investigation include:
- Inflammatory bowel disease models — reduction of colonic inflammation markers in preclinical models of ulcerative colitis and Crohn's-like disease, including downregulation of TNF-α, IL-6, and IL-1β
- Gut mucosal integrity — research into epithelial barrier function, tight junction preservation, and intestinal permeability under inflammatory challenge
- Melanocortin receptor signalling — investigation of MC1R and MC3R-mediated anti-inflammatory pathways in immune cell populations
- Dermatological inflammation — preclinical models examining wound healing, psoriasis, and atopic dermatitis via topical and systemic administration routes
- Systemic immunomodulation — broad suppression of pro-inflammatory cytokine cascades across multiple tissue types without immunosuppressive side effect profiles observed in conventional agents
- Oral bioavailability research — study of tripeptide stability under gastrointestinal conditions and transepithelial absorption kinetics
Quality Assurance
Every batch of NueCog KPV is manufactured using solid-phase peptide synthesis (SPPS) and undergoes rigorous third-party analytical testing including HPLC purity analysis and mass spectrometry confirmation. Certificate of Analysis (CoA) available on request.
Intended Use
This product is sold strictly for laboratory and in-vitro research purposes only. It is not intended for human consumption, veterinary use, or diagnostic application. Not for sale to minors. This product is not a medicine, food supplement, or drug.
This product is sold strictly for research purposes only. Not intended for human consumption. By purchasing, you confirm you are a qualified researcher operating in a proper laboratory setting.
- Choosing a selection results in a full page refresh.
- Opens in a new window.